<DOC>
	<DOC>NCT01940198</DOC>
	<brief_summary>This observational study will aim to determine long-term atazanavir experience in a high HIV caseload primary care practice in Sydney, Australia.</brief_summary>
	<brief_title>Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia</brief_title>
	<detailed_description>This observational study will aim to determine long term atazanavir experience in HIV-1 infected patients in a primary care setting. 3. OBJECTIVES OF THE STUDY i. Primary objective Long-term (2 years or greater) atazanavir experience in HIV-1 infected patients in a primary care setting through retrospective data collection. ii. Secondary objectives 1. To illustrate long term therapeutic efficacy of atazanavir in ART na誰ve and experienced HIV-1 infected patients. 2. To illustrate long term tolerability to atazanavir in ART na誰ve and experienced HIV-1 infected patients. 3. To identify ART treatment history in ART na誰ve and experienced HIV-1 infected patients on ATV. 4. To identify contraindicated therapy in ART na誰ve and experienced HIV-1 infected patients on ATV.</detailed_description>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>1. HIV1 positive 2. Have commenced ATV between 20022008 (Baseline) 3. Followup data (clinical and laboratory) available from baseline 1. Patients not commenced ATV between 20022008 2. No followup data (clinical and laboratory) available from baseline 3. Patient 'lost to followup' with &lt; 2 years of followup data (Clinical and laboratory)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Atazanavir</keyword>
	<keyword>long-term</keyword>
	<keyword>primary care setting</keyword>
	<keyword>sydney</keyword>
</DOC>